|
|
|
|
LEADER |
00000cam a22000002 4500 |
001 |
1840045299 |
003 |
DE-627 |
005 |
20230325055040.0 |
007 |
cr uuu---uuuuu |
008 |
230324s2004 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.3886/ICPSR03903.v6
|2 doi
|
035 |
|
|
|a (DE-627)1840045299
|
035 |
|
|
|a (DE-599)KXP1840045299
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
041 |
|
|
|a eng
|
084 |
|
|
|a 2,1
|2 ssgn
|
110 |
2 |
|
|a United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies
|e VerfasserIn
|4 aut
|
245 |
1 |
0 |
|a National Survey on Drug Use and Health, 2002
|
264 |
|
1 |
|a [Erscheinungsort nicht ermittelbar]
|b [Verlag nicht ermittelbar]
|c 2004
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
520 |
|
|
|a The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey includes questions concerning treatment for both substance abuse and mental health related disorders. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2002 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2002 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
|
540 |
|
|
|a ICPSR Terms of Use
|
650 |
|
4 |
|a Addiction
|
650 |
|
4 |
|a Alcohol
|
650 |
|
4 |
|a Alcohol abuse
|
650 |
|
4 |
|a Alcohol consumption
|
650 |
|
4 |
|a amphetamines
|
650 |
|
4 |
|a barbiturates
|
650 |
|
4 |
|a Cocaine
|
650 |
|
4 |
|a controlled drugs
|
650 |
|
4 |
|a depression (psychology)
|
650 |
|
4 |
|a drinking behavior
|
650 |
|
4 |
|a Drug Abuse
|
650 |
|
4 |
|a Drug dependence
|
650 |
|
4 |
|a Drug treatment
|
650 |
|
4 |
|a Drug use
|
650 |
|
4 |
|a Drugs
|
650 |
|
4 |
|a Hallucinogens
|
650 |
|
4 |
|a Heroin
|
650 |
|
4 |
|a Households
|
650 |
|
4 |
|a inhalants
|
650 |
|
4 |
|a Marijuana
|
650 |
|
4 |
|a Mental Health
|
650 |
|
4 |
|a Mental Health Services
|
650 |
|
4 |
|a Methamphetamine
|
650 |
|
4 |
|a Prescription Drugs
|
650 |
|
4 |
|a sedatives
|
650 |
|
4 |
|a Smoking
|
650 |
|
4 |
|a stimulants
|
650 |
|
4 |
|a Substance Abuse
|
650 |
|
4 |
|a Substance Abuse Treatment
|
650 |
|
4 |
|a tranquilizers
|
655 |
|
7 |
|a Forschungsdaten
|0 (DE-588)1098579690
|0 (DE-627)857755366
|0 (DE-576)469182156
|2 gnd-content
|
856 |
4 |
0 |
|u https://doi.org/10.3886/ICPSR03903.v6
|x Resolving-System
|z kostenfrei
|3 Volltext
|
935 |
|
|
|a mkri
|
951 |
|
|
|a BO
|
ELC |
|
|
|a 1
|
LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
LOK |
|
|
|0 001 4296792636
|
LOK |
|
|
|0 003 DE-627
|
LOK |
|
|
|0 004 1840045299
|
LOK |
|
|
|0 005 20230324125150
|
LOK |
|
|
|0 008 230324||||||||||||||||ger|||||||
|
LOK |
|
|
|0 035
|a (DE-2619)ICPSR3903
|
LOK |
|
|
|0 040
|a DE-2619
|c DE-627
|d DE-2619
|
LOK |
|
|
|0 092
|o n
|
LOK |
|
|
|0 852
|a DE-2619
|
LOK |
|
|
|0 852 1
|9 00
|
LOK |
|
|
|0 935
|a foda
|a nacj
|
OAS |
|
|
|a 1
|
ORI |
|
|
|a SA-MARC-krimdoka001.raw
|